AdAlta Limited Profile Avatar - Palmy Investing

AdAlta Limited

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibr…

Biotechnology
AU, Melbourne [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of 1AD.AX's Analysis
CIK: - CUSIP: Q0101X107 ISIN: AU0000001AD2 LEI: - UEI: -
Secondary Listings
1AD.AX has no secondary listings inside our databases.